36 results
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing
424B4
m6wtl
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
EX-1.1
sb2zly h1e
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
8-K
EX-1.1
daq 00563sijo11dd0
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm